Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Gabapentin NDC 10135-645 by Marlex Pharmaceuticals Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Creatinine clearance (CLCr) is difficult to measure in outpatients. In patients with stable renal function, creatinine clearance can be reasonably well estimated using the equation of Cockcroft and Gault: - gabapentin capsules 01

Creatinine clearance (CLCr) is difficult to measure in outpatients. In patients with stable renal function, creatinine clearance can be reasonably well estimated using the equation of Cockcroft and Gault: - gabapentin capsules 01

The structural formual for Gabapentin, USP is a white to off-white crystalline solid with a pKa1 of 4.72±0.10 and a pKa2 of 10.27±0.29. It is freely soluble in water and both basic and acidic aqueous solutions. The log of the partition coefficient is -1.083±0.235 at 25°C temperature. - gabapentin capsules 02

The structural formual for Gabapentin, USP is a white to off-white crystalline solid with a pKa1 of 4.72±0.10 and a pKa2 of 10.27±0.29. It is freely soluble in water and both basic and acidic aqueous solutions. The log of the partition coefficient is -1.083±0.235 at 25°C temperature. - gabapentin capsules 02

In two of the three controlled studies, more than one dose of gabapentin was used. Within each study, the results did not show a consistently increased response to dose. However, looking across studies, a trend toward increasing efficacy with increasing dose is evident (see Figure 4). - gabapentin capsules 03

In two of the three controlled studies, more than one dose of gabapentin was used. Within each study, the results did not show a consistently increased response to dose. However, looking across studies, a trend toward increasing efficacy with increasing dose is evident (see Figure 4). - gabapentin capsules 03

PRINCIPAL DISPLAY PANELNDC 10135-0644-01GabapentinCapsules, USP100 mg100 Capsules Rx Only - gabapentin capsules 04

PRINCIPAL DISPLAY PANELNDC 10135-0644-01GabapentinCapsules, USP100 mg100 Capsules Rx Only - gabapentin capsules 04

This is a listing for a medication with an NDC code of 10135-0644-01. The medication is Gabapentin, USP in capsule form with a dosage of 100 mg. The recommended dosage is indicated in the accompanying prescribing information. It should be stored within a specific temperature range and within a container with a child-resistant closure. Manufactured for and distributed by Marlex Pharmaceuticals. There are 100 capsules in each container.*

PRINCIPAL DISPLAY PANELNDC 10135-0644-05GabapentinCapsules, USP100 mg500 Capsules Rx Only - gabapentin capsules 05

PRINCIPAL DISPLAY PANELNDC 10135-0644-05GabapentinCapsules, USP100 mg500 Capsules Rx Only - gabapentin capsules 05

NDC 10135-0644-05 is a Gabapentin drug in capsule form distributed by Marlex Pharmaceuticals. Each capsule contains 100mg of Gabapentin. It is prescription-only medication and comes in a bottle of 500 capsules. The usual dosage should be read in the prescribing information that accompanies the drug. The drug should be stored between 20°C to 25°C. The container should be tight and have a child-resistant closure.*

PRINCIPAL DISPLAY PANELNDC 10135-0645-01GabapentinCapsules, USP300 mg100 Capsules Rx Only - gabapentin capsules 06

PRINCIPAL DISPLAY PANELNDC 10135-0645-01GabapentinCapsules, USP300 mg100 Capsules Rx Only - gabapentin capsules 06

Marl% Gabapentin capsules, each containing 300mg of Gabapentin, USP. Typically prescribed as part of a treatment plan, it is important to read accompanying prescribing information with this medication. It is recommended to store at a controlled room temperature of 20° to 25°C (68°F to 77°F) with excursions permitted to 15° to 30°C (56°F to 86°F). This medication should be dispensed in a tight container with a child-resistant closure as required. Marlex Pharmaceuticals, Inc. manufactures and distributes this product in New Castle, DE.*

PRINCIPAL DISPLAY PANELNDC 10135-0645-05GabapentinCapsules, USP300 mg500 Capsules Rx Only - gabapentin capsules 07

PRINCIPAL DISPLAY PANELNDC 10135-0645-05GabapentinCapsules, USP300 mg500 Capsules Rx Only - gabapentin capsules 07

This is a medication package for Gabapentin Capsules, USP containing 300 mg of Gabapentin. It comes in a child-resistant closure and should be kept away from children. It is distributed by Marlex Pharmaceutical, Inc. in Delaware. The usual dosage information is not available, but the accompanying prescribing information can provide it. The medication should be stored between 20 to 25 degrees Celsius, with allowable excursions between 15 to 30 degrees Celsius as per the USP controlled room temperature guidelines. The revision date of the package is March 2018.*

PRINCIPAL DISPLAY PANELNDC 10135-0646-01GabapentinCapsules, USP400 mg100 Capsules Rx Only - gabapentin capsules 08

PRINCIPAL DISPLAY PANELNDC 10135-0646-01GabapentinCapsules, USP400 mg100 Capsules Rx Only - gabapentin capsules 08

PRINCIPAL DISPLAY PANELNDC 10135-0646-05GabapentinCapsules, USP400 mg500 Capsules Rx Only - gabapentin capsules 09

PRINCIPAL DISPLAY PANELNDC 10135-0646-05GabapentinCapsules, USP400 mg500 Capsules Rx Only - gabapentin capsules 09

Gabapentin capsules, each containing 400mg of the active ingredient, are provided in child-resistant packaging. Usual dosage information is included on accompanying prescribing information. This medication is manufactured and distributed by Marlex Pharmaceuticals and should be stored at temperatures between 20°C and 25°C. Keep out of reach of children.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.